neurological disorders

Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...

Cambridge, Massachusetts, September 15, 2026 QurCan Therapeutics has entered into a strategic research and collaboration agreement with Eli Lilly...

Paris, France and New York, USA, September 14, 2026 Cyllene Therapeutics announced that the U.S. Food and Drug Administration...

Melbourne, Australia, September 10, 2026 Nutromics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...

Tokyo, Japan and Cambridge, UK, September 3, 2026 Nxera Pharma announced that Centessa Pharmaceuticals, a wholly owned subsidiary of...

MINNEAPOLIS, Minnesota, Aug. 31, 2026 The American Academy of Neurology (AAN) and the American Headache Society (AHS) have issued...

FORT LAUDERDALE, Fla., July 7, 2026 Splash Beverage Group, Inc. has announced the acquisition of exclusive global licensing rights...

NEW YORK, July 7, 2026 The American Parkinson Disease Association (APDA) has announced the launch of “Bridging Mental Health...

TOKYO, Japan and FRANKFURT, Germany, June 19, 2026 Teijin Pharma Limited and Merz Therapeutics GmbH have announced that Japan’s...

PARAMUS, N.J., June 15, 2026 SK Life Science, Inc. has announced that the U.S. Food and Drug Administration (FDA)...